Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Understanding mood changes during pregnancy and after birth

Official title: Perinatal Thymic Dysregulation: Characterization of Perinatal Mood Episodes

Run by Centre Hospitalier Charles Perrens, Bordeaux · NCT07008183 · Data updated 2026-11-12

This project will see if using brief self-questionnaires during routine psychiatric visits helps standardize diagnosis and detect depressive, hypomanic, or mixed mood episodes in pregnant women and those up to one year after giving birth.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment200 (estimated)
SponsorCentre Hospitalier Charles Perrens, Bordeaux
Government
Locations1 site (Bordeaux, New Aquitaine)
StatusRecruiting
StartedOctober 13, 2025
Main results expectedJuly 31, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 1, 2025
Trial IDNCT07008183 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older who are pregnant or within one year postpartum presenting for their first psychiatric consultation about the current pregnancy, fluent in French, and affiliated with the French social security system.

Probably not a fit

Women already under psychiatric care, under court protection, or more than one year postpartum are not eligible and unlikely to receive benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program integrates standardized self-report questionnaires into routine first psychiatric consultations for women who are pregnant or within 12 months postpartum. It aims to capture a broad range of perinatal mood presentations, including depressive, hypomanic, manic, and mixed features that are often under-recognized. The protocol records clinical criteria and contextual factors to better characterize episode patterns and guide therapeutic management. Participation requires French fluency, social security affiliation, and informed consent.

Why it matters

Potential benefit: If successful, this approach could enable earlier and more accurate recognition of perinatal hypomanic and mixed episodes, leading to improved treatment decisions and outcomes.

How similar studies have gone: Prior research has mainly targeted perinatal depression, and systematic capture of hypomanic and mixed symptoms in routine care remains relatively novel with limited prior evidence of effectiveness.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women over 18 years old
* Pregnant or having given birth less than a year ago
* First psychiatric consultation for the pregnancy concerned.
* Good command of the French language.
* Participant affiliated to the social security system
* Participant who has given her consent to take part in the study.

Exclusion Criteria:

* Women who gave birth more than a year ago.
* Participant under psychiatric care
* Participant under court protection

Where it's running

  • Centre Hospitalier CHARLES PERRENS
    Bordeaux, New Aquitaine, France
    Recruiting

Study contacts

  • Principal investigator: Anne-Laure SUTTER-DALLAY, Prof Md PhD — Centre Hospitalier Charles Perrens
  • Study coordinator: Anne-Laure SUTTER DALLAY, Prof, MD, PhD
  • Email: alsutter@ch-perrens.fr
  • Phone: +33 556561782

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.